ICD-10 Coding for Transitional Cell Carcinoma(C67.2, C67.9)
Complete ICD-10-CM coding and documentation guide for Transitional Cell Carcinoma. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Transitional Cell Carcinoma
C67.0-C67.9Primary Range
Malignant neoplasm of bladder
This range includes codes for bladder cancer, specifying the site within the bladder.
Carcinoma in situ of bladder
Used for non-invasive bladder carcinoma, important for staging and treatment planning.
Code Comparison: When to Use Each Code
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C67.2 | Malignant neoplasm of lateral wall of bladder | Use when pathology confirms TCC on the lateral wall of the bladder. |
|
| C67.9 | Malignant neoplasm of bladder, unspecified | Use when the specific site of the bladder tumor is not documented. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information: ICD-10 code for transitional cell carcinoma
Essential facts and insights about Transitional Cell Carcinoma
Primary ICD-10-CM Codes for transitional cell carcinoma
Decision Criteria
documentation Criteria
- Document the specific site of the tumor within the bladder.
Applicable To
- Transitional cell carcinoma of lateral wall
Excludes
- Benign neoplasm of bladder (D30.3)
Clinical Validation Requirements
- Pathology report confirming transitional cell carcinoma
- Imaging showing tumor on lateral wall
Code-Specific Risks
- Misclassification if tumor site is not specified
Coding Notes
- Ensure documentation specifies the exact location of the tumor within the bladder.
C67.9 - Malignant neoplasm of bladder, unspecified
Use when the specific site of the bladder tumor is not documented.
Excludes
- Benign neoplasm of bladder (D30.3)
Clinical Validation Requirements
- General diagnosis of bladder cancer without specific site
Coding Notes
Encourage documentation of the specific tumor site to avoid using unspecified codes.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Personal history of malignant neoplasm of bladder
Z85.51Differential Codes
Alternative codes to consider when ruling out similar conditions to the primary diagnosis.
Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Transitional Cell Carcinoma to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C67.2.
Impact
Clinical: May lead to confusion in clinical communication., Regulatory: Non-compliance with updated terminology standards., Financial: Potential for claim denials if terminology is not aligned with coding standards.
Mitigation Strategy
Use 'urothelial carcinoma' in clinical documentation., Update templates and forms to reflect current terminology.
Impact
Reimbursement: May result in lower reimbursement due to lack of specificity., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases accuracy of cancer registry data.
Mitigation Strategy
Ensure the specific site is coded, such as C67.2 for lateral wall.
Impact
Audits may focus on whether the specific site of bladder tumors is documented and coded.
Mitigation Strategy
Ensure all clinical documentation specifies the tumor site within the bladder.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Transitional Cell Carcinoma, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Transitional Cell Carcinoma
Use these documentation templates to ensure complete and accurate documentation for Transitional Cell Carcinoma. These templates include all required elements for proper coding and billing.
Bladder cancer diagnosis and treatment
Specialty: UrologyRequired Elements
- Tumor location
- Histology type
- Stage and grade
- Treatment plan
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Transitional Cell Carcinoma? Ask your questions below.